Conmed (CNMD) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
Revenue Growth %: -0.5%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -0.5%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $193.4 million versus the consensus estimate of $191.48 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coca-Cola beats third quarter estimates on strong revenue
- Watsco (WSO) Misses Q3 EPS by 35c
- Sherwin-Williams (SHW) Misses Q3 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
